Xenofon Baraliakos (X Baraliakos)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 177

Top Venues

Annals of the rheumatic diseases

RMD open

Rheumatology and therapy

Arthritis & rheumatology (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Madeline Deike, Jiancong Wang, Ralph Brinks, Stephan Meller, Lennart Ocker, Falk G Bechara, Jörg H W Distler, Xenofon Baraliakos, David Kiefer, Philipp Sewerin
Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population. Archives of dermatological research 316 (2) (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, Désirée van der Heijde, Atul A Deodhar, Pedro M Machado, Victoria Navarro-Compán, Kay-Geert A Hermann, Kishimoto Mitsumasa, Eun Young Lee, Lianne S Gensler, Uta Kiltz, Marco F Eigenmann, Patricia Pertel, Aimee Readie, Hanno B Richards, Brian Porter, Juergen Braun
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Xenofon Baraliakos, Pedro M Machado, Lars Bauer, Bengt Hoepken, Mindy Kim, Thomas Kumke, Rachel Tham, Martin Rudwaleit
Comparison of established and preliminarily proposed ASAS MRI working group cut-offs for inflammatory MRI lesions in the sacroiliac joints in radiographic and non-radiographic axial spondyloarthritis. RMD open 10 (3) (2024)
Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, Reinhard E Voll, Ferdinand C Breedveld, Josef S Smolen, Jacques-Eric Gottenberg, Xenofon Baraliakos, Hans P Kiener, Daniel Aletaha, John Dudley Isaacs, Maya H Buch, Mary K Crow, Jonathan Kay, Leslie J Crofford, Ronald F Van Vollenhoven, Caroline Ospelt, Stefan Siebert, Margreet Kloppenburg, Iain B McInnes, Thomas Wj Huizinga, Ellen M Gravallese
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023. Annals of the rheumatic diseases 83 (4) (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology 6 (8) (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Andri Phoka, Bartholomeus J F van den Bemt, Ennio Lubrano, Inderjit Singh, Cristina Fernández-Carballido, Detlev Parow, Dale Webb, Fabienne Lacombe, Laura Harrington, Xenofon Baraliakos
Elevating the Standard of Care for Patients with Axial Spondyloarthritis: 'Calls to Action' from Rheumacensus, a Multistakeholder Pan-European Initiative. Rheumatology and therapy (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Manouk de Hooge, Roos Stal, Alexandre Sepriano, Xenofon Baraliakos, Monique Reijnierse, Jüergen Braun, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen
Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis. RMD open 10 (2) (2024)
Xenofon Baraliakos, Annette E Szumski, Kenneth K Kwok, Bonnie Vlahos, Cecilia E Borlenghi
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies. Rheumatology and therapy 11 (3) (2024)
Alen Zabotti, Filippo Fagni, Laure Gossec, Ivan Giovannini, Michael Sticherling, Annarita Tullio, Xenofon Baraliakos, Gabriele de Marco, Salvatore De Vita, Enzo Errichetti, Luca Quartuccio, Ettore Silvagni, Josef S Smolen, Ilaria Tinazzi, Abdulla Watad, Georg Schett, Dennis G McGonagle, David Simon
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage. RMD open 10 (2) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Alen Zabotti, Filippo Fagni, Laure Gossec, Ivan Giovannini, Michael Sticherling, Annarita Tullio, Xenofon Baraliakos, Gabriele de Marco, Salvatore De Vita, Enzo Errichetti, Luca Quartuccio, Ettore Silvagni, Josef S Smolen, Ilaria Tinazzi, Abdulla Watad, Georg Schett, Dennis G McGonagle, David Simon
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage. RMD open 10 (2) (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology 6 (8) (2024)
Andri Phoka, Bartholomeus J F van den Bemt, Ennio Lubrano, Inderjit Singh, Cristina Fernández-Carballido, Detlev Parow, Dale Webb, Fabienne Lacombe, Laura Harrington, Xenofon Baraliakos
Elevating the Standard of Care for Patients with Axial Spondyloarthritis: 'Calls to Action' from Rheumacensus, a Multistakeholder Pan-European Initiative. Rheumatology and therapy 11 (3) (2024)
Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, Reinhard E Voll, Ferdinand C Breedveld, Josef S Smolen, Jacques-Eric Gottenberg, Xenofon Baraliakos, Hans P Kiener, Daniel Aletaha, John Dudley Isaacs, Maya H Buch, Mary K Crow, Jonathan Kay, Leslie J Crofford, Ronald F Van Vollenhoven, Caroline Ospelt, Stefan Siebert, Margreet Kloppenburg, Iain B McInnes, Thomas Wj Huizinga, Ellen M Gravallese
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023. Annals of the rheumatic diseases 83 (4) (2024)
Alen Zabotti, Filippo Fagni, Laure Gossec, Ivan Giovannini, Michael Sticherling, Annarita Tullio, Xenofon Baraliakos, Gabriele de Marco, Salvatore De Vita, Enzo Errichetti, Luca Quartuccio, Ettore Silvagni, Josef S Smolen, Ilaria Tinazzi, Abdulla Watad, Georg Schett, Dennis G McGonagle, David Simon
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage. RMD open 10 (2) (2024)
Martin Fruth, Lucie Künitz, Philipp Martin-Seidel, Styliani Tsiami, Xenofon Baraliakos
MRI of shoulder girdle in polymyalgia rheumatica: inflammatory findings and their diagnostic value. RMD open 10 (2) (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Madeline Deike, Jiancong Wang, Ralph Brinks, Stephan Meller, Lennart Ocker, Falk G Bechara, Jörg H W Distler, Xenofon Baraliakos, David Kiefer, Philipp Sewerin
Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population. Archives of dermatological research 316 (2) (2024)
Xenofon Baraliakos, Dafna D Gladman, Soumya D Chakravarty, Cinty Gong, May Shawi, Emmanouil Rampakakis, Kishimoto Mitsumasa, Enrique Roberto Soriano, Phillip J Mease
BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studies. Rheumatology advances in practice 8 (2) (2024)
Andri Phoka, Bartholomeus J F van den Bemt, Ennio Lubrano, Inderjit Singh, Cristina Fernández-Carballido, Detlev Parow, Dale Webb, Fabienne Lacombe, Laura Harrington, Xenofon Baraliakos
Elevating the Standard of Care for Patients with Axial Spondyloarthritis: 'Calls to Action' from Rheumacensus, a Multistakeholder Pan-European Initiative. Rheumatology and therapy 11 (3) (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Madeline Deike, Jiancong Wang, Ralph Brinks, Stephan Meller, Lennart Ocker, Falk G Bechara, Jörg H W Distler, Xenofon Baraliakos, David Kiefer, Philipp Sewerin
Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population. Archives of dermatological research 316 (2) (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Xenofon Baraliakos, Annette E Szumski, Kenneth K Kwok, Bonnie Vlahos, Cecilia E Borlenghi
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies. Rheumatology and therapy 11 (3) (2024)
Martin Fruth, Lucie Künitz, Philipp Martin-Seidel, Styliani Tsiami, Xenofon Baraliakos
MRI of shoulder girdle in polymyalgia rheumatica: inflammatory findings and their diagnostic value. RMD open 10 (2) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Nelly Ziadé, Melanie Udod, Nikolaos Kougkas, Styliani Tsiami, Xenofon Baraliakos
Significant overlap of inflammatory and degenerative features on imaging among patients with degenerative disc disease, diffuse idiopathic skeletal hyperostosis and axial spondyloarthritis: a real-life cohort study. Arthritis research & therapy 26 (1) (2024)
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, Désirée van der Heijde, Atul A Deodhar, Pedro M Machado, Victoria Navarro-Compán, Kay-Geert A Hermann, Kishimoto Mitsumasa, Eun Young Lee, Lianne S Gensler, Uta Kiltz, Marco F Eigenmann, Patricia Pertel, Aimee Readie, Hanno B Richards, Brian Porter, Juergen Braun
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study. Arthritis & rheumatology (Hoboken, N.J.) 76 (8) (2024)
Madeline Deike, Jiancong Wang, Ralph Brinks, Stephan Meller, Lennart Ocker, Falk G Bechara, Jörg H W Distler, Xenofon Baraliakos, David Kiefer, Philipp Sewerin
Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population. Archives of dermatological research 316 (2) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Robert G W Lambert, Xenofon Baraliakos, Stephanie A Bernard, John A Carrino, Torsten Diekhoff, Iris Eshed, Kay-Geert A Hermann, Nele Herregods, Jacob L Jaremko, Lennart B O Jans, Anne Grethe Jurik, John M D O'Neill, Monique Reijnierse, Michael J Tuite, Walter P Maksymowych
Development of international consensus on a standardised image acquisition protocol for diagnostic evaluation of the sacroiliac joints by MRI: an ASAS-SPARTAN collaboration. Annals of the rheumatic diseases (2024)
Manouk de Hooge, Roos Stal, Alexandre Sepriano, Xenofon Baraliakos, Monique Reijnierse, Jüergen Braun, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen
Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis. RMD open 10 (2) (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology (2024)
Manouk de Hooge, Roos Stal, Alexandre Sepriano, Xenofon Baraliakos, Monique Reijnierse, Jüergen Braun, Désirée Mfm van der Heijde, Floris A van Gaalen, Josef S Smolen
Inflammation in the posterior elements, in particular the facet joint and facet joint ankylosis over 2-year follow-up in radiographic axial spondyloarthritis. RMD open 10 (2) (2024)
Xenofon Baraliakos, Annette E Szumski, Kenneth K Kwok, Bonnie Vlahos, Cecilia E Borlenghi
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies. Rheumatology and therapy 11 (3) (2024)
Alen Zabotti, Filippo Fagni, Laure Gossec, Ivan Giovannini, Michael Sticherling, Annarita Tullio, Xenofon Baraliakos, Gabriele de Marco, Salvatore De Vita, Enzo Errichetti, Luca Quartuccio, Ettore Silvagni, Josef S Smolen, Ilaria Tinazzi, Abdulla Watad, Georg Schett, Dennis G McGonagle, David Simon
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage. RMD open 10 (2) (2024)
Xenofon Baraliakos, Annette E Szumski, Kenneth K Kwok, Bonnie Vlahos, Cecilia E Borlenghi
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies. Rheumatology and therapy (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases 83 (6) (2024)
Torsten Diekhoff, Iris Eshed, Chiara Giraudo, Hildrun Haibel, Kay-Geert A Hermann, Manouk de Hooge, Lennart B O Jans, Anne Grethe Jurik, Robert G W Lambert, Pedro M Machado, Michael Mallinson, Walter P Maksymowych, Helena Marzo-Ortega, Victoria Navarro-Compán, Mikkel Østergaard, Susanne J Pedersen, Monique Reijnierse, Martin Rudwaleit, Fernando Andrés Sommerfleck, Ulrich Weber, Xenofon Baraliakos, Denis Poddubnyy
Reporting Sacroiliac Joint Imaging Performed for Known or Suspected Axial Spondyloarthritis: Assessment of SpondyloArthritis International Society Recommendations. Radiology 311 (3) (2024)
Xenofon Baraliakos, Annette E Szumski, Kenneth K Kwok, Bonnie Vlahos, Cecilia E Borlenghi
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies. Rheumatology and therapy 11 (3) (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology 6 (8) (2024)
Madeline Deike, Jiancong Wang, Ralph Brinks, Stephan Meller, Lennart Ocker, Falk G Bechara, Jörg H W Distler, Xenofon Baraliakos, David Kiefer, Philipp Sewerin
Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population. Archives of dermatological research 316 (2) (2024)
Madeline Deike, Jiancong Wang, Ralph Brinks, Stephan Meller, Lennart Ocker, Falk G Bechara, Jörg H W Distler, Xenofon Baraliakos, David Kiefer, Philipp Sewerin
Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population. Archives of dermatological research 316 (2) (2024)
Imke Redeker, Stefan Moustakis, Styliani Tsiami, Xenofon Baraliakos, David Kiefer, Ioana Andreica, Björn Buehring, Jüergen Braun, Uta Kiltz
A Bayesian model to analyse the association of comorbidities with biosimilar treatment retention in a non-medical switch scenario in patients with inflammatory rheumatic musculoskeletal diseases. Arthritis research & therapy 26 (1) (2024)
Martin Fruth, Lucie Künitz, Philipp Martin-Seidel, Styliani Tsiami, Xenofon Baraliakos
MRI of shoulder girdle in polymyalgia rheumatica: inflammatory findings and their diagnostic value. RMD open 10 (2) (2024)
Alen Zabotti, Filippo Fagni, Laure Gossec, Ivan Giovannini, Michael Sticherling, Annarita Tullio, Xenofon Baraliakos, Gabriele de Marco, Salvatore De Vita, Enzo Errichetti, Luca Quartuccio, Ettore Silvagni, Josef S Smolen, Ilaria Tinazzi, Abdulla Watad, Georg Schett, Dennis G McGonagle, David Simon
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage. RMD open 10 (2) (2024)
Xenofon Baraliakos, Dafna D Gladman, Soumya D Chakravarty, Cinty Gong, May Shawi, Emmanouil Rampakakis, Kishimoto Mitsumasa, Enrique Roberto Soriano, Phillip J Mease
BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studies. Rheumatology advances in practice 8 (2) (2024)
Madeline Deike, Jiancong Wang, Ralph Brinks, Stephan Meller, Lennart Ocker, Falk G Bechara, Jörg H W Distler, Xenofon Baraliakos, David Kiefer, Philipp Sewerin
Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population. Archives of dermatological research 316 (2) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases (2024)
Nelly Ziadé, Melanie Udod, Nikolaos Kougkas, Styliani Tsiami, Xenofon Baraliakos
Significant overlap of inflammatory and degenerative features on imaging among patients with degenerative disc disease, diffuse idiopathic skeletal hyperostosis and axial spondyloarthritis: a real-life cohort study. Arthritis research & therapy 26 (1) (2024)
Andreas Kerschbaumer, Josef S Smolen, Ricardo Jorge de Oliveira Ferreira, Heidi Bertheussen, Xenofon Baraliakos, Daniel Aletaha, Dennis G McGonagle, Désirée Mfm van der Heijde, Iain B McInnes, Bente Appel Esbensen, Kevin L Winthrop, Wolf-Henning Boehncke, Johan A F Koekkoek, Laure Gossec
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the rheumatic diseases (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Andri Phoka, Bartholomeus J F van den Bemt, Ennio Lubrano, Inderjit Singh, Cristina Fernández-Carballido, Detlev Parow, Dale Webb, Fabienne Lacombe, Laura Harrington, Xenofon Baraliakos
Elevating the Standard of Care for Patients with Axial Spondyloarthritis: 'Calls to Action' from Rheumacensus, a Multistakeholder Pan-European Initiative. Rheumatology and therapy 11 (3) (2024)
David Kiefer, Kristina Vaupel, Uta Kiltz, Ludwig Hammel, Yvonne M van der Kraan, Suzanne Arends, Xenofon Baraliakos
[German translation and linguistic validation of the modified short questionnaire to assess health-enhancing physical activity (mSQUASH) for patients with axial spondyloarthritis (axSpA)]. Zeitschrift fur Rheumatologie (2024)
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, Désirée van der Heijde, Atul A Deodhar, Pedro M Machado, Victoria Navarro-Compán, Kay-Geert A Hermann, Kishimoto Mitsumasa, Eun Young Lee, Lianne S Gensler, Uta Kiltz, Marco F Eigenmann, Patricia Pertel, Aimee Readie, Hanno B Richards, Brian Porter, Juergen Braun
Effect of secukinumab versus adalimumab biosimilar on radiographic progression in patients with radiographic axial spondyloarthritis: Results from a head-to-head randomized phase IIIb study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Andri Phoka, Bartholomeus J F van den Bemt, Ennio Lubrano, Inderjit Singh, Cristina Fernández-Carballido, Detlev Parow, Dale Webb, Fabienne Lacombe, Laura Harrington, Xenofon Baraliakos
Elevating the Standard of Care for Patients with Axial Spondyloarthritis: 'Calls to Action' from Rheumacensus, a Multistakeholder Pan-European Initiative. Rheumatology and therapy 11 (3) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Torsten Diekhoff, Iris Eshed, Chiara Giraudo, Hildrun Haibel, Kay-Geert A Hermann, Manouk de Hooge, Lennart B O Jans, Anne Grethe Jurik, Robert G W Lambert, Pedro M Machado, Michael Mallinson, Walter P Maksymowych, Helena Marzo-Ortega, Victoria Navarro-Compán, Mikkel Østergaard, Susanne J Pedersen, Monique Reijnierse, Martin Rudwaleit, Fernando Andrés Sommerfleck, Ulrich Weber, Xenofon Baraliakos, Denis Poddubnyy
Reporting Sacroiliac Joint Imaging Performed for Known or Suspected Axial Spondyloarthritis: Assessment of SpondyloArthritis International Society Recommendations. Radiology 311 (3) (2024)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy (2023)
Elenore Judy B Uy, Jie Kie Phang, Ting Hui Woon, Jean W Liew, M Hassan Murad, Fabian Proft, Josef S Smolen, Anna Moltó, Victoria Navarro-Compán, Manouk de Hooge, Bhowmik Meghnathi, Nelly Ziadé, Sizheng Steven Zhao, Maria Llop, Xenofon Baraliakos, Weng Seng Warren Fong
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. Journal of medical Internet research 25 (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy 23 (2) (2023)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Thilo Klopsch, Anja Plenske, Lisa K Blindzellner, Pascal Klaus, Thomas Meng, Peter-Andreas Löschmann
Correction: Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes. Rheumatology and therapy (2023)
Andreas Reich, Anja Weiß, Lisa Lindner, Xenofon Baraliakos, Denis Poddubnyy, Silke Zinke, Carsten Stille, Anja Strangfeld, Anne Constanze Regierer
Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohort. Arthritis research & therapy 25 (1) (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Xenofon Baraliakos, Atul A Deodhar, Désirée Mfm van der Heijde, Marina Magrey, Walter P Maksymowych, Tetsuya Tomita, Huji Xu, Ute Massow, Carmen Fleurinck, Alicia M Ellis, Thomas Vaux, Julie Shepherd-Smith, Alexander Marten, Lianne S Gensler
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies. Annals of the rheumatic diseases (2023)
Elenore Judy B Uy, Jie Kie Phang, Ting Hui Woon, Jean W Liew, M Hassan Murad, Fabian Proft, Josef S Smolen, Anna Moltó, Victoria Navarro-Compán, Manouk de Hooge, Bhowmik Meghnathi, Nelly Ziadé, Sizheng Steven Zhao, Maria Llop, Xenofon Baraliakos, Weng Seng Warren Fong
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. Journal of medical Internet research 25 (2023)
Elenore Judy B Uy, Jie Kie Phang, Ting Hui Woon, Jean W Liew, M Hassan Murad, Fabian Proft, Josef S Smolen, Anna Moltó, Victoria Navarro-Compán, Manouk de Hooge, Bhowmik Meghnathi, Nelly Ziadé, Sizheng Steven Zhao, Maria Llop, Xenofon Baraliakos, Weng Seng Warren Fong
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. Journal of medical Internet research 25 (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Alen Zabotti, Gabriele De Marco, Laure Gossec, Xenofon Baraliakos, Daniel Aletaha, AnnaMaria Iagnocco, Paolo Gisondi, Peter V Balint, Heidi Bertheussen, Wolf-Henning Boehncke, Nemanja S Damjanov, Maarten P T de Wit, Enzo Errichetti, Helena Marzo-Ortega, Mikhail Protopopov, Lluis Puig, Rubén Queiro, Roberto Caporali, Laura Savage, Larissa Valor-Méndez, Stefan Siebert, Tanja Alexandra Stamm, Paul Studenic, Ilaria Tinazzi, Filip E Van den Bosch, Annette van der Helm-van Mil, Giovanni Damiani, Josef S Smolen, Dennis G McGonagle
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. Annals of the rheumatic diseases (2023)
Raphael Micheroli, Seraphina Kissling, Kristina Bürki, Burkhard Möller, Axel Finckh, Michael John Nissen, Pascale Exer, René Bräm, Diego Kyburz, Andrea Rubbert-Roth, Michael Andor, Xenofon Baraliakos, Manouk de Hooge, Oliver Distler, Almut Scherer, Adrian Ciurea
Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry. Clinical rheumatology (2023)
Matthias Augustin, Lisa Lindner, Laura Kühl, Anja Weiß, Stephan Jeff Rustenbach, Brigitte Stephan, Martin Feuchtenberger, Ulrich Mrowietz, Diamant Thaçi, Petra Staubach, Xenofon Baraliakos, Anja Strangfeld, Ralph von Kiedrowski, Frank Behrens, Anne Constanze Regierer
Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2023)
David Kiefer, Jüergen Braun, Uta Kiltz, Varvara Chatzistefanidi, Daniela Adolf, Ilka Schwarze, Maria Kabelitz, Uwe Lange, Jan Brandt-Jürgens, Edgar Stemmler, Sabine Sartingen, Xenofon Baraliakos
Global functioning in axial spondyloarthritis is stronger associated with disease activity and function than with mobility and radiographic damage. Arthritis care & research (2023)
Désirée Mfm van der Heijde, Anna Moltó, Josef S Smolen, Jüergen Braun, Maxime Dougados, Floris A van Gaalen, Lianne S Gensler, Robert Davies Inman, Robert B M Landewe, Helena Marzo-Ortega, Victoria Navarro-Compán, Andri Phoka, Denis Poddubnyy, Mikhail Protopopov, John D Reveille, Martin Rudwaleit, Percival Sampaio-Barros, Alexandre Sepriano, Joachim Sieper, Filip E Van den Bosch, Irene van der Horst-Bruinsma, Pedro M Machado, Xenofon Baraliakos
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature. Annals of the rheumatic diseases (2023)
Anne Constanze Regierer, Anja Weiß, Fabian Proft, Xenofon Baraliakos, Frank Behrens, Denis Poddubnyy, Georg Schett, Hanns-Martin Lorenz, Matthias Worsch, Anja Strangfeld
Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA. RMD open 9 (1) (2023)
Victoria Navarro-Compán, Xenofon Baraliakos, Marina N Magrey, Andrew Östör, Christopher D Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul A Deodhar
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis. Rheumatology and therapy (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Anne Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Rosalinde Anne Stal, Josef S Smolen, Désirée Mfm van der Heijde, Floris A van Gaalen, Xenofon Baraliakos, Pedro M Machado, Manouk de Hooge, Rosaline van den Berg, Monique Reijnierse, Jüergen Braun, Robert B M Landewe, Alexandre Sepriano
Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial. RMD open 9 (3) (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Matthias Augustin, Lisa Lindner, Laura Kühl, Anja Weiß, Stephan Jeff Rustenbach, Brigitte Stephan, Martin Feuchtenberger, Ulrich Mrowietz, Diamant Thaçi, Petra Staubach, Xenofon Baraliakos, Anja Strangfeld, Ralph von Kiedrowski, Frank Behrens, Anne Constanze Regierer
Charakterisierung von Patienten mit Psoriasisarthritis in der dermatologischen und rheumatologischen Versorgung: Analyse von zwei Registern: Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 21 (10) (2023)
Victoria Navarro-Compán, Xenofon Baraliakos, Marina N Magrey, Andrew Östör, Christopher D Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul A Deodhar
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis. Rheumatology and therapy (2023)
Gabriele de Marco, Alen Zabotti, Xenofon Baraliakos, AnnaMaria Iagnocco, Daniel Aletaha, Paulo Gisondi, Jenny Emmel, Josef S Smolen, Dennis G McGonagle, Laure Gossec
Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce. RMD open 9 (2) (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy 23 (2) (2023)
Caroline Ensslin, Raphael Micheroli, Seraphina Kissling, Andrea Götschi, Kristina Bürki, René Bräm, Manouk de Hooge, Xenofon Baraliakos, Michael John Nissen, Burkhard Möller, Pascale Exer, Michael Andor, Oliver Distler, Almut Scherer, Adrian Ciurea
Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years. RMD open 9 (3) (2023)
Xenofon Baraliakos, Roberto Ranza, Andrew Östör, Francesco Ciccia, Laura C Coates, Simona Rednic, Jessica A Walsh, Kevin Douglas, Tianming Gao, Koji Kato, In-Ho Song, Fabiana Ganz, Atul Deodhar
Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies. Arthritis research & therapy 25 (1) (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Anne Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Phillip J Mease, Dafna D Gladman, Denis Poddubnyy, Soumya D Chakravarty, May Shawi, Alexa P Kollmeier, Xie L Xu, Stephen Xu, Atul Deodhar, Xenofon Baraliakos
Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study. Rheumatology and therapy (2023)
Gabriele de Marco, Alen Zabotti, Xenofon Baraliakos, AnnaMaria Iagnocco, Daniel Aletaha, Paulo Gisondi, Jenny Emmel, Josef S Smolen, Dennis G McGonagle, Laure Gossec
Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce. RMD open 9 (2) (2023)
Mary Lucy Marques, Nuno Pereira da Silva, Désirée Mfm van der Heijde, Rosalinde Anne Stal, Xenofon Baraliakos, Jüergen Braun, Monique Reijnierse, Caroline Bastiaenen, Josef S Smolen, Floris A van Gaalen
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis. RMD open 9 (1) (2023)
Xenofon Baraliakos, Désirée van der Heijde, Joachim Sieper, Robert D Inman, Hideto Kameda, Yihan Li, Xianwei Bu, Anna Shmagel, Peter Wung, In-Ho Song, Atul Deodhar
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study. Arthritis research & therapy 25 (1) (2023)
Jiancong Wang, Sabrina Tulka, Stephanie Knippschild, Matthias Schneider, Jörg H W Distler, Xenofon Baraliakos, Ralph Brinks, Philipp Sewerin
A population-based projection of psoriatic arthritis in Germany until 2050: analysis of national statutory health insurance data of 65 million German population. Rheumatology international (2023)
Alessia Alunno, Tadej Avcin, Catherine Haines, Josef S Smolen, Francisca Sivera, Sara Badreh, Xenofon Baraliakos, Johannes W J Bijlsma, Frank Buttgereit, Kaushik Chaudhuri, José António Pereira Da Silva, Jean Dudler, Ricardo Jorge de Oliveira Ferreira, Tania Gudu, Eric Hachulla, Mette Holland-Fischer, AnnaMaria Iagnocco, Tue Wenzel Kragstrup, György Nagy, Vasco C Romão, Simon R Stones, Marloes van Onna, Christopher J Edwards
Points to consider: EULAR-UEMS standards for the training of European rheumatologists. Annals of the rheumatic diseases (2023)

Xenofon Baraliakos.css-eqlu8i{font-size:small;padding-left:4px;} (X Baraliakos)

Publication Activity (10 Years)

Top Topics

Top Venues

Xenofon Baraliakos (X Baraliakos)